Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05406167 · ClinicalTrials.gov registry record
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
A clinical trial of Cancer and Cancer Central Nervous System, sponsored by RefleXion Medical.
- Recruiting
- Registry status
- 500
- Enrollment target
- 5
- Study locations
NCT05406167 is a study of Cancer and Cancer Central Nervous System that is actively recruiting participants, run by RefleXion Medical. The registered enrollment target is 500 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT05406167, a study of Cancer and Cancer Central Nervous System, is actively recruiting participants, sponsored by RefleXion Medical.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this prospective cohort study is to assess clinical and quality of life measures as well as to define the severity of adverse effects for the use of the RefleXion system to deliver intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), or SCINTIX Biology-guided radiotherapy (BgRT) in standard of care (SOC) use in the treatment of local,loco-regionally advanced, and oligometastatic malignancies. In addition, patient costs and charges will be analyzed to quantify the health economic impact of this modality. Workflow and quality of radiotherapy planning including a collection of dosimetric data will also be analyzed.
Conditions Studied
Interventions
- DEVICE Registry - Observational
Study Locations (5)
California
- City Of Hope - Duarte
- Stanford Cancer Center - Palo Alto
Connecticut
- Yale University - Cancer Center - New Haven
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Texas
- UT Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-04-12 |
| Est. Completion | 2026-04-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05406167
The ClinicalTrials.gov registry entry for NCT05406167 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The listed sponsor is RefleXion Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Registry - Observational is the first listed.
NCT05406167 reports 5 study locations spanning 4 distinct geographic areas - top geographies include California, Connecticut, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05406167 about?
NCT05406167 is a clinical study titled "Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System". The purpose of this prospective cohort study is to assess clinical and quality of life measures as well as to define the severity of adverse effects for the use of the RefleXion system to deliver intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), or SCINTIX Biology-guide...
What is the current status of trial NCT05406167?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-04-12. Estimated completion is 2026-04-25.
What conditions does trial NCT05406167 study?
This clinical trial studies the following conditions: Cancer, Cancer Central Nervous System, Cancer Thoracic, Cancer, Gastrointestinal, Cancer Gynecologic.
What interventions are being tested in trial NCT05406167?
The interventions under investigation include: Registry - Observational (DEVICE).
Who is sponsoring clinical trial NCT05406167?
This trial is sponsored by RefleXion Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05406167 being conducted?
This trial has 5 study locations across California, Connecticut, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.